145 related articles for article (PubMed ID: 31492540)
1. Cancer of the oesophagus and lymph nodes management in the neoadjuvant or definitive radiochemotherapy setting.
Bourbonné V; Pradier O; Schick U; Servagi-Vernat S
Cancer Radiother; 2019 Oct; 23(6-7):682-687. PubMed ID: 31492540
[TBL] [Abstract][Full Text] [Related]
2. [Radiochemotherapy for esophageal cancer: which nodes should be irradiated?].
Créhange G; Quivrin M; Vulquin N; Serre AA; Maingon P
Cancer Radiother; 2014 Oct; 18(5-6):577-82. PubMed ID: 25201634
[TBL] [Abstract][Full Text] [Related]
3. [Lymph node involvement in œsophageal cancer: surgical approach].
Gronnier C; Mariette C
Cancer Radiother; 2014 Oct; 18(5-6):559-64. PubMed ID: 25195112
[TBL] [Abstract][Full Text] [Related]
4. Phase II feasibility study of preoperative concurrent chemoradiotherapy with cisplatin plus 5-fluorouracil and elective lymph node irradiation for clinical stage II/III esophageal squamous cell carcinoma.
Hashimoto J; Kato K; Ito Y; Kojima T; Akimoto T; Daiko H; Hamamoto Y; Matsushita H; Katano S; Hara H; Tanaka Y; Saito Y; Nagashima K; Igaki H
Int J Clin Oncol; 2019 Jan; 24(1):60-67. PubMed ID: 30109544
[TBL] [Abstract][Full Text] [Related]
5. Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification.
Schneider PM; Baldus SE; Metzger R; Kocher M; Bongartz R; Bollschweiler E; Schaefer H; Thiele J; Dienes HP; Mueller RP; Hoelscher AH
Ann Surg; 2005 Nov; 242(5):684-92. PubMed ID: 16244542
[TBL] [Abstract][Full Text] [Related]
6. Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practice.
Li M; Zhang X; Zhao F; Luo Y; Kong L; Yu J
Radiat Oncol; 2016 Feb; 11():18. PubMed ID: 26846932
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of concurrent chemoradiotherapy with elective nodal irradiation for inoperable esophageal cancer.
Jing Z; Chen T; Zhang X; Wu S
Cancer Sci; 2017 Sep; 108(9):1828-1833. PubMed ID: 28665042
[TBL] [Abstract][Full Text] [Related]
8. Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution.
Castoro C; Scarpa M; Cagol M; Ruol A; Cavallin F; Alfieri R; Zanchettin G; Rugge M; Ancona E
Ann Surg Oncol; 2011 Dec; 18(13):3743-54. PubMed ID: 21556952
[TBL] [Abstract][Full Text] [Related]
9. Target volume delineation for radical radiotherapy of early oesophageal carcinoma in elderly patients.
Su J; Zhu S; Liu Z; Zhao Y; Song C
Cancer Radiother; 2017 Feb; 21(1):34-39. PubMed ID: 28041813
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy for Esophageal Adenocarcinoma.
Kwong DLW; Lam KO
Methods Mol Biol; 2018; 1756():7-17. PubMed ID: 29600356
[TBL] [Abstract][Full Text] [Related]
11. Elective nodal irradiation versus involved-field irradiation in patients with esophageal cancer receiving neoadjuvant chemoradiotherapy: a network meta-analysis.
Liu T; Ding S; Dang J; Wang H; Chen J; Li G
Radiat Oncol; 2019 Oct; 14(1):176. PubMed ID: 31619265
[TBL] [Abstract][Full Text] [Related]
12. Influence of neoadjuvant chemoradiation on the number and size of analyzed lymph nodes in esophageal cancer.
Bollschweiler E; Besch S; Drebber U; Schröder W; Mönig SP; Vallböhmer D; Baldus SE; Metzger R; Hölscher AH
Ann Surg Oncol; 2010 Dec; 17(12):3187-94. PubMed ID: 20585867
[TBL] [Abstract][Full Text] [Related]
13. Reduced radiation dose for elective nodal irradiation in node-negative anal cancer: back to the roots?
Henkenberens C; Meinecke D; Michael S; Bremer M; Christiansen H
Strahlenther Onkol; 2015 Nov; 191(11):845-54. PubMed ID: 26307627
[TBL] [Abstract][Full Text] [Related]
14. [Constraints of the dentist are consistent with the results of an optimal irradiation with modulated intensity in N0 oropharyngeal cancer].
Jaussaud S; Guihard S; Niederst C; Borel C; Meyer P; Hémar P; Schultz P; Noël G; Féki A
Cancer Radiother; 2013; 17(4):265-71. PubMed ID: 23726044
[TBL] [Abstract][Full Text] [Related]
15. Involved-field radiotherapy (IFRT) versus elective nodal irradiation (ENI) in combination with concurrent chemotherapy for 239 esophageal cancers: a single institutional retrospective study.
Yamashita H; Takenaka R; Omori M; Imae T; Okuma K; Ohtomo K; Nakagawa K
Radiat Oncol; 2015 Aug; 10():171. PubMed ID: 26269033
[TBL] [Abstract][Full Text] [Related]
16. [Lung cancer and elective nodal irradiation: A solved issue?].
Laurans M; Botticella A; Moukasse Y; Lévy A; Le Péchoux C
Cancer Radiother; 2019 Oct; 23(6-7):701-707. PubMed ID: 31501024
[TBL] [Abstract][Full Text] [Related]
17. Concurrent chemoradiotherapy with elective lymph node irradiation for esophageal cancer: a systemic review and pooled analysis of the literature.
Du D; Song T; Liang X; Fang M; Wu S
Dis Esophagus; 2017 Feb; 30(2):1-9. PubMed ID: 26918886
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant chemoradiotherapy followed by esophagectomy for initially resectable squamous cell carcinoma of the esophagus with multiple lymph node metastasis.
Nabeya Y; Ochiai T; Matsubara H; Okazumi S; Shiratori T; Shuto K; Aoki T; Miyazaki S; Gunji Y; Uno T; Ito H; Shimada H
Dis Esophagus; 2005; 18(6):388-97. PubMed ID: 16336610
[TBL] [Abstract][Full Text] [Related]
19. Oncologic Outcomes According to Remnant Lymph Node Metastases in Pathologic T0 (ypT0) Esophageal Squamous Cell Carcinoma Following Prospective Neoadjuvant Therapy and Surgery.
Cho HJ; Kim YH; Kim HR; Kim DK; Park SI; Kim JH; Kim SB
Ann Surg Oncol; 2015; 22(6):1851-7. PubMed ID: 25344308
[TBL] [Abstract][Full Text] [Related]
20. [Radiotherapy in cancers of the oesophagus, the gastric cardia and the stomach].
Créhange G; Huguet F; Quero L; N'Guyen TV; Mirabel X; Lacornerie T
Cancer Radiother; 2016 Sep; 20 Suppl():S161-8. PubMed ID: 27523409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]